These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3319348)

  • 1. Clinical pharmacokinetic significance of the renal tubular secretion of digoxin.
    Koren G
    Clin Pharmacokinet; 1987 Nov; 13(5):334-43. PubMed ID: 3319348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular mechanisms of digoxin transport and toxic interactions in the kidney.
    Koren G; Klein J; MacLeod S; Silverman M
    Vet Hum Toxicol; 1986 Dec; 28(6):549-52. PubMed ID: 3538641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of quinidine on the renal tubular and biliary transport of digoxin: in vivo and in vitro studies in the dog.
    Koren G; Klein J; Giesbrecht E; Ben Dayan R; Soldin S; Sellers E; MacLeod S; Silverman M
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1193-8. PubMed ID: 3204514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic digoxin-drug interactions: the major role of renal P-glycoprotein.
    Koren G; Woodland C; Ito S
    Vet Hum Toxicol; 1998 Feb; 40(1):45-6. PubMed ID: 9467211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of the verapamil-digoxin interaction in renal tubular cells (LLC-PK1).
    Ito S; Woodland C; Harper PA; Koren G
    Life Sci; 1993; 53(24):PL399-403. PubMed ID: 8246676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model for the prediction of digoxin-drug interactions at the renal tubular cell level.
    Woodland C; Ito S; Koren G
    Ther Drug Monit; 1998 Apr; 20(2):134-8. PubMed ID: 9558126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P-glycoprotein-mediated renal tubular secretion of digoxin: the toxicological significance of the urine-blood barrier model.
    Ito S; Woodland C; Harper PA; Koren G
    Life Sci; 1993; 53(2):PL25-31. PubMed ID: 8100040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of P-glycoprotein in renal tubular secretion of digoxin in the isolated perfused rat kidney.
    Hori R; Okamura N; Aiba T; Tanigawara Y
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1620-5. PubMed ID: 8103798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of the digoxin-quinidine and digoxin-verapamil interactions in the rat kidney.
    Koren G; MacLeod SM
    Res Commun Chem Pathol Pharmacol; 1984 Jul; 45(1):3-18. PubMed ID: 6473899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1).
    Tanigawara Y; Okamura N; Hirai M; Yasuhara M; Ueda K; Kioka N; Komano T; Hori R
    J Pharmacol Exp Ther; 1992 Nov; 263(2):840-5. PubMed ID: 1359120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From bench to bedside: utilization of an in vitro model to predict potential drug-drug interactions in the kidney: the digoxin-mifepristone example.
    Woodland C; Koren G; Ito S
    J Clin Pharmacol; 2003 Jul; 43(7):743-50. PubMed ID: 12856388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The digoxin-propafenone interaction: characterization of a mechanism using renal tubular cell monolayers.
    Woodland C; Verjee Z; Giesbrecht E; Koren G; Ito S
    J Pharmacol Exp Ther; 1997 Oct; 283(1):39-45. PubMed ID: 9336306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Handling of digoxin and ouabain by renal tubular cells (LLC-PK1).
    Ito S; Koren G; Harper PA
    J Pharmacol Exp Ther; 1992 Jul; 262(1):109-13. PubMed ID: 1320681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Energy-dependent transport of digoxin across renal tubular cell monolayers (LLC-PK1).
    Ito S; Koren G; Harper PA; Silverman M
    Can J Physiol Pharmacol; 1993 Jan; 71(1):40-7. PubMed ID: 8099844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal handling and effects of [3H]digoxin and interactions with quinidine in the avian kidney.
    Milton A; Odlind B; Dencker L
    Acta Physiol Scand; 1986 May; 127(1):9-16. PubMed ID: 3014819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal drug transport: a review.
    Bendayan R
    Pharmacotherapy; 1996; 16(6):971-85. PubMed ID: 8947968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions in the renal and biliary elimination of digoxin: stereoselective difference between quinine and quinidine.
    Hedman A; Angelin B; Arvidsson A; Dahlqvist R; Nilsson B
    Clin Pharmacol Ther; 1990 Jan; 47(1):20-6. PubMed ID: 2295215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digoxin-cyclosporin A interaction: modulation of the multidrug transporter P-glycoprotein in the kidney.
    Okamura N; Hirai M; Tanigawara Y; Tanaka K; Yasuhara M; Ueda K; Komano T; Hori R
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1614-9. PubMed ID: 8103797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digoxin-amiodarone interaction: in vivo and in vitro studies in rats.
    Koren G; Soldin S; Macleod SM
    Can J Physiol Pharmacol; 1983 Dec; 61(12):1483-6. PubMed ID: 6671160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of mannitol diuresis on digoxin and phenobarbital handling by the kidney: implications for tubular reabsorption and secretion of the cardiac glycoside.
    Koren G; Klein J; Bentur Y; Giesbrecht E
    Clin Invest Med; 1989 Oct; 12(5):279-84. PubMed ID: 2513154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.